Skip to main content
LobbyMap

Amgen Inc

Pharmaceutical & Health Products · Lobbying Client

B
Influence Score
63/100
High Influence
$17.1M
Total Lobby Spend
4
Policy Issues
6
Lobbyists
3
Revolving Door

Amgen Inc reported $17.1 million in federal lobbying expenditures as disclosed in Senate LDA filings. The organization's lobbying activity spans 4 policy areas, with primary focus on Health Issues, Pharmacy, Medical/Disease Research. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995. All lobbying disclosure data sourced from Senate lobbying disclosure filings filed under the Lobbying Disclosure Act.

Annual Lobbying Spend

Policy Issues

Government Entities Contacted

Dept of Commerce
Federal Communications Commission
US Trade Representative
Dept of Agriculture
Securities & Exchange Commission
Centers for Medicare & Medicaid Services

Recent Filings

PeriodRegistrantIssuesLobbyistsAmount
2020 Jan-MarBrownstein Hyatt LLP
HCRPHAGOV
2$727K
2020 Apr-JunBGR Group LLP
HCR
2$1.1M
2020 Jul-SepCovington & Burling LLP
GOVMED
2$820K
2020 Oct-DecBrownstein Hyatt LLP
HCRMEDGOV+1
2$1.1M
2021 Jan-MarSquire Patton Boggs LLP
PHAMEDGOV+1
3$1.0M
2021 Apr-JunCovington & Burling LLP
HCRGOV
1$1.1M
2021 Jul-SepCassidy & Associates LLP
GOVHCR
1$987K
2021 Oct-DecBrownstein Hyatt LLP
HCRPHA
4$984K

Amgen Inc Lobbying FAQ

Amgen Inc has spent $17.1M on federal lobbying across 4 policy areas. This includes spending on registered lobbyists and direct government contacts.

Amgen Inc lobbies on 4 policy issues, including Health Issues, Pharmacy, Medical/Disease Research, Government Issues. These disclosures are filed quarterly with the Senate Office of Public Records.

Amgen Inc has an Influence Score of 63/100 (Grade B). This proprietary score is based on total lobby spend (40%), policy issue breadth (30%), and revolving door connections (30%).

Amgen Inc employs 6 registered lobbyists, of whom 3 have revolving door connections — meaning they previously held government positions before becoming lobbyists.

Amgen Inc has contacted 6 government entities as part of their lobbying activities, including Dept of Commerce, Federal Communications Commission, US Trade Representative.

Sources: Senate Office of Public Records (LDA), OpenSecrets.org
Last updated:

Lobbying data is sourced from quarterly Lobbying Disclosure Act (LDA) filings with the Senate Office of Public Records. Influence Scores combine total spend (40%), issue breadth (30%), and revolving door connections (30%). Filings may be amended after initial submission.